{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:36:54Z","timestamp":1792201014400,"version":"4.4.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.psychres.2025.116764","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T12:52:35Z","timestamp":1760532755000},"page":"116764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparative efficacy and safety of Clozapine vs. Quetiapine in schizophrenia and related disorders: An updated systematic review"],"prefix":"10.1016","volume":"353","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8264-0524","authenticated-orcid":false,"given":"Claudia","family":"Asenjo-Lobos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2239-6248","authenticated-orcid":false,"given":"Marcelo","family":"Arancibia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Garcia-Ribera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Cort\u00e9s-Jofr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianming","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6434-5436","authenticated-orcid":false,"given":"Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8095-5549","authenticated-orcid":false,"given":"Eva","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.psychres.2025.116764_bib0001","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1177\/070674371005501007","article-title":"Where to position Clozapine: re-examining the evidence","volume":"55","author":"Agid","year":"2010","journal-title":"Can. J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0002","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41537-024-00447-3","article-title":"Changes in kynurenine metabolites in the gray and white matter of the dorsolateral prefrontal cortex of individuals affected by schizophrenia","volume":"10","author":"Antenucci","year":"2024","journal-title":"Schizophrenia"},{"issue":"11","key":"10.1016\/j.psychres.2025.116764_bib0003","article-title":"Clozapine versus other atypical antipsychotics for schizophrenia","author":"Asenjo-Lobos","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.psychres.2025.116764_bib0004","article-title":"Clozapine versus quetiapine for people with schizophrenia","author":"Asenjo-Lobos","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2025.116764_bib0005","series-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-5-TR)","author":"Association","year":"2022"},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0006","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/schbul\/sbp116","article-title":"The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements","volume":"36","author":"Buchanan","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"5","key":"10.1016\/j.psychres.2025.116764_bib0007","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrn3475","article-title":"Power failure: why small sample size undermines the reliability of neuroscience","volume":"14","author":"Button","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0008","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1046\/j.1365-2125.1999.00849.x","article-title":"The use of atypical antipsychotics in the management of schizophrenia","volume":"47","author":"Campbell","year":"1999","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2025.116764_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/ph14030238","article-title":"Atypical antipsychotics and metabolic syndrome: from molecular mechanisms to clinical differences","volume":"14","author":"Carli","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"4","key":"10.1016\/j.psychres.2025.116764_bib0010","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1176\/appi.ajp.158.4.518","article-title":"Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials","volume":"158","author":"Chakos","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2025.116764_bib0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00023210-200418030-00004","volume":"18","author":"Cheer","year":"2004","journal-title":"Quetiapine. CNS Drugs"},{"issue":"2\u20133","key":"10.1016\/j.psychres.2025.116764_bib0012","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000065140","article-title":"Chinese classification of mental disorders (CCMD-3): towards integration in International classification","volume":"35","author":"Chen","year":"2002","journal-title":"Psychopathology"},{"key":"10.1016\/j.psychres.2025.116764_bib0013","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.schres.2023.09.027","article-title":"A systematic review and meta-analysis of the effect of clozapine on cognitive functions in patients with treatment-resistant schizophrenia","volume":"268","author":"Cheuk","year":"2024","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116764_bib0014","first-page":"357","article-title":"Global economic burden of schizophrenia: a systematic review","volume":"12","author":"Chong","year":"2016","journal-title":"Neuropsychiatr. Dis. Treatm."},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2025.116764_bib0015","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4088\/JCP.13049su1c.04","article-title":"Unmet needs in the treatment of schizophrenia: new targets to help different symptom domains","volume":"75","author":"Citrome","year":"2014","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116764_bib0016","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/mi.8.2.7","article-title":"Schizophrenia","volume":"8","author":"Conn","year":"2008","journal-title":"Mol. Interv."},{"issue":"7109","key":"10.1016\/j.psychres.2025.116764_bib0017","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2025.116764_bib73","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s40263-016-0352-5","article-title":"Antipsychotic drug-induced somnolence: Incidence, mechanisms, and management","volume":"30","author":"Fang","year":"2016","journal-title":"CNS Drugs"},{"issue":"6","key":"10.1016\/j.psychres.2025.116764_bib0018","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1093\/eurpub\/cky231","article-title":"A systematic review of the indirect costs of schizophrenia in Europe","volume":"28","author":"Fasseeh","year":"2018","journal-title":"Eur. J. Public Health"},{"issue":"2","key":"10.1016\/j.psychres.2025.116764_bib0019","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/schbul\/sbn094","article-title":"Negative symptoms in schizophrenia: avolition and Occam's razor","volume":"36","author":"Foussias","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"18","key":"10.1016\/j.psychres.2025.116764_bib0020","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia","volume":"349","author":"Freedman","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.psychres.2025.116764_bib0021","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.neuropharm.2011.03.015","article-title":"NMDA receptors, cognition and schizophrenia\u2013testing the validity of the NMDA receptor hypofunction hypothesis","volume":"62","author":"Gilmour","year":"2012","journal-title":"Neuropharmacology."},{"issue":"4","key":"10.1016\/j.psychres.2025.116764_bib0022","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1192\/bja.2022.27","article-title":"Management of sedation due to clozapine","volume":"29","author":"Gupta","year":"2023","journal-title":"BJPsych Adv."},{"issue":"9","key":"10.1016\/j.psychres.2025.116764_bib0023","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/chromsci\/bmac100","article-title":"Quetiapine Fumarate: a review of analytical methods","volume":"61","author":"Hamsa","year":"2023","journal-title":"J. Chromatogr. Sci."},{"issue":"2","key":"10.1016\/j.psychres.2025.116764_bib0024","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3329\/bjpsy.v29i2.37851","article-title":"Factors associated with relapse of schizophrenia","volume":"29","author":"Haque","year":"2018","journal-title":"Bangladesh J. Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41537-024-00483-z","article-title":"Elevated serum kynurenic acid in individuals with first-episode psychosis and insufficient response to antipsychotics","volume":"10","author":"Hatzimanolis","year":"2024","journal-title":"Schizophrenia"},{"key":"10.1016\/j.psychres.2025.116764_bib0026","series-title":"Cochrane Handbook for Systematic Reviews of Interventions","article-title":"Chapter 8: assessing risk of bias in included studies","author":"Higgins JPT","year":"2011"},{"issue":"10202","key":"10.1016\/j.psychres.2025.116764_bib0027","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"7321","key":"10.1016\/j.psychres.2025.116764_bib0028","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature09552","article-title":"Rethinking schizophrenia","volume":"468","author":"Insel","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0029","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/wps.20284","article-title":"Psychiatric classifications: validity and utility","volume":"15","author":"Jablensky","year":"2016","journal-title":"World Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2025.116764_bib0030","article-title":"History of suicide attempt and clozapine treatment in veterans with schizophrenia or schizoaffective disorder","volume":"24","author":"Jones","year":"2022","journal-title":"Prim. Care Companion. CNS. Disord."},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2015.67","article-title":"Schizophrenia","volume":"1","author":"Kahn","year":"2015","journal-title":"Nat. Rev. Dis. Primers."},{"issue":"9","key":"10.1016\/j.psychres.2025.116764_bib0032","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic: a double-blind comparison with Chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116764_bib0033","series-title":"Positive and Negative Syndrome Scale (PANSS) Manual","author":"Kay","year":"1986"},{"issue":"6","key":"10.1016\/j.psychres.2025.116764_bib0034","doi-asserted-by":"crossref","first-page":"770","DOI":"10.4103\/IJPSYM.IJPSYM_111_17","article-title":"Efficacy and tolerability of Clozapine versus Quetiapine in treatment-resistant schizophrenia","volume":"39","author":"Kumar","year":"2017","journal-title":"Indian J. Psychol. Med."},{"issue":"3","key":"10.1016\/j.psychres.2025.116764_bib0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14587","article-title":"The protective effect of clozapine on suicide: a population mortality study of statewide autopsy records in Maryland","volume":"84","author":"Lee","year":"2023","journal-title":"J. Clin. Psychiatry"},{"issue":"9896","key":"10.1016\/j.psychres.2025.116764_bib0036","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"issue":"9657","key":"10.1016\/j.psychres.2025.116764_bib0037","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.psychres.2025.116764_bib0038","first-page":"219","article-title":"A study of quetiapine and clozapine in treatment of the first episode schizophrenia","volume":"28","author":"Li","year":"2002","journal-title":"Chin. J. Nerv. Ment. Dis."},{"key":"10.1016\/j.psychres.2025.116764_bib0039","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3389\/fpsyt.2018.00622","article-title":"Antipsychotics, metabolic adverse effects, and cognitive function in schizophrenia","volume":"9","author":"MacKenzie","year":"2018","journal-title":"Front. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2025.116764_bib0040","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.2025.13479","article-title":"Metabolic syndrome in patients with schizophrenia: underlying mechanisms and therapeutic approaches (Review)","volume":"31","author":"Manta","year":"2025","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.psychres.2025.116764_bib0041","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1136\/eb-2015-102214","article-title":"Alpha-7 nicotinic agonist improves cognition in schizophrenia","volume":"19","author":"Marder","year":"2016","journal-title":"Evid. Based. Ment. Health"},{"issue":"5","key":"10.1016\/j.psychres.2025.116764_bib0042","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia andemployment","volume":"39","author":"Marwaha","year":"2004","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"issue":"6","key":"10.1016\/j.psychres.2025.116764_bib0043","first-page":"635","article-title":"Clozapine prescription trends in Brazil in the last decade","volume":"44","author":"Massuda","year":"2022","journal-title":"Braz. J. Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2025.116764_bib0044","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-023-01949-9","article-title":"Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment","volume":"28","author":"McCutcheon","year":"2023","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psychres.2025.116764_bib70","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1176\/ajp.2006.163.4.600","article-title":"Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment","volume":"163","author":"McEvoy","year":"2006","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.psychres.2025.116764_bib0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrd3628","article-title":"Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy","volume":"11","author":"Millan","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.psychres.2025.116764_bib0046","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4103\/0253-7184.102130","article-title":"Randomized double blind placebo control studies, the \"Gold Standard\" in intervention based studies","volume":"33","author":"Misra","year":"2012","journal-title":"Indian J. Sex. Transm. Dis. AIDS"},{"issue":"5","key":"10.1016\/j.psychres.2025.116764_bib0047","doi-asserted-by":"crossref","first-page":"286","DOI":"10.3949\/ccjm.88a.20031","article-title":"Quetiapine for primary insomnia: consider the risks","volume":"88","author":"Modesto-Lowe","year":"2021","journal-title":"Cleve. Clin. J. Med."},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0048","doi-asserted-by":"crossref","first-page":"25","DOI":"10.9758\/cpn.2015.13.1.25","article-title":"Pharmacotherapy of bipolar disorder with Quetiapine: a recent literature review and an update","volume":"13","author":"Muneer","year":"2015","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.psychres.2025.116764_bib71","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.schres.2014.12.024","article-title":"Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: Analysis of the CATIE phase 2E data","volume":"161","author":"Nakajima","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116764_bib0049","series-title":"ICD-11: International statistical Classification of Diseases and Related Health Problems","author":"Organization","year":"2019"},{"issue":"10039","key":"10.1016\/j.psychres.2025.116764_bib0050","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","article-title":"Schizophrenia","volume":"388","author":"Owen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2025.116764_bib72","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s002130050017","article-title":"Atypical antipsychotics: are some more atypical than others?","volume":"148","author":"Remington","year":"2000","journal-title":"Psychopharmacology (Berl.)"},{"issue":"6","key":"10.1016\/j.psychres.2025.116764_bib0051","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00406-007-0739-x","article-title":"Effects of risperidone and quetiapine on cognition in patients with schizophrenia and predominantly negative symptoms","volume":"257","author":"Riedel","year":"2007","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0052","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pctr.0010009","article-title":"Factors that can affect the external validity of randomised controlled trials","volume":"1","author":"Rothwell","year":"2006","journal-title":"PLoS. Clin. Trials"},{"issue":"2","key":"10.1016\/j.psychres.2025.116764_bib0053","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2010.07.012","article-title":"Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis","volume":"123","author":"Rummel-Kluge","year":"2010","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0054","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00213-022-06294-3","article-title":"Prevalence of clozapine-induced sialorrhea and its effect on quality of life","volume":"240","author":"Sanagustin","year":"2023","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.psychres.2025.116764_bib0055","series-title":"Chapter 12: Interpreting results and Drawing conclusions, Cochrane Handbook For Systematic Reviews of Interventions","first-page":"359","author":"Sch\u00fcnemann","year":"2011"},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0056","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can. J. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2025.116764_bib0057","doi-asserted-by":"crossref","first-page":"e933","DOI":"10.4088\/JCP.16m11152","article-title":"Evaluating the effect of the changes in FDA guidelines for clozapine monitoring","volume":"78","author":"Sultan","year":"2017","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2025.116764_bib0058","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/hup.642","article-title":"Quetiapine has a direct effect on the negative symptoms of schizophrenia","volume":"19","author":"Tandon","year":"2004","journal-title":"Hum. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.psychres.2025.116764_bib0059","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.2051-5545.2008.tb00154.x","article-title":"Side effects of atypical antipsychotics: a brief overview","volume":"7","author":"\u00dc\u00e7ok","year":"2008","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2025.116764_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.psychres.2023.115539","article-title":"Comprehensive dissection of prevalence rates, sex differences, and blood level-dependencies of clozapine-associated adverse drug reactions","volume":"330","author":"van der Horst","year":"2023","journal-title":"Psychiatry Res."},{"issue":"Suppl 4","key":"10.1016\/j.psychres.2025.116764_bib0061","first-page":"1","article-title":"The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness","volume":"70","author":"Velligan","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.psychres.2025.116764_bib0062","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.schres.2009.03.035","article-title":"Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis","volume":"113","author":"Ventura","year":"2009","journal-title":"Schizophr. Res."},{"issue":"6","key":"10.1016\/j.psychres.2025.116764_bib0063","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1176\/appi.ajp.20230396","article-title":"Durability of effects of cognitive remediation on cognition and psychosocial functioning in schizophrenia: a systematic review and meta-analysis of randomized clinical trials","volume":"181","author":"Vita","year":"2024","journal-title":"Am. J. Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.psychres.2025.116764_bib0064","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.schres.2007.08.002","article-title":"Cognition, functioning and quality of life in schizophrenia treatment: results of a one-year randomized controlled trial of olanzapine and quetiapine","volume":"96","author":"Voruganti","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2025.116764_bib0065","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.903156","article-title":"Antipsychotic drug development: from historical evidence to fresh perspectives","volume":"13","author":"Weston-Green","year":"2022","journal-title":"Front. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2025.116764_bib0066","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.27163","article-title":"Hippocampal availability of the \u03b17 nicotinic acetylcholine receptor in recent-onset psychosis","volume":"7","author":"Wong","year":"2024","journal-title":"JAMa Netw. Open."},{"issue":"12","key":"10.1016\/j.psychres.2025.116764_bib0067","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s40263-021-00859-0","article-title":"Antipsychotic-induced constipation: a review of the pathogenesis","volume":"35","author":"Xu","year":"2021","journal-title":"Clin. Diagn. Treat., CNS Drugs"},{"key":"10.1016\/j.psychres.2025.116764_bib0068","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.609240","article-title":"A focused review of the metabolic side-effects of Clozapine","volume":"12","author":"Yuen","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.psychres.2025.116764_bib0069","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2147\/NDT.S424694","article-title":"The relationship between level of education, cognitive function and medication adherence in patients with schizophrenia","volume":"19","author":"Zhu","year":"2023","journal-title":"Neuropsychiatr. Dis. Treat."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125004093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178125004093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T05:00:16Z","timestamp":1780549216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178125004093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":73,"alternative-id":["S0165178125004093"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116764","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of Clozapine vs. Quetiapine in schizophrenia and related disorders: An updated systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2025.116764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116764"}}